The global Stem Cell Manufacturing market accrued earnings worth approximately 11.2(USD Billion) in 2020 and is predicted to gain revenue of about 21.1(USD Billion) by 2028, is set to record a CAGR of nearly 9.5% over the period from 2021 to 2028.
The global Stem Cell Manufacturing market accrued earnings worth approximately 11.2(USD Billion) in 2020 and is predicted to gain revenue of about 21.1(USD Billion) by 2028, is set to record a CAGR of nearly 9.5% over the period from 2021 to 2028. The report offers assessment and analysis of the Stem Cell Manufacturing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).
Report Scope :
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
Stem cells possess huge potential for developing new cell treatments for unfulfilled medical requirements. Moreover, key aim of producing cell-based products is to manufacture large amounts of viable, healthy, and phenotypically as well as genotypically stable cells, and the production of stem cells is no exception to this. Apart from this, industry players focus on devising stem cell manufacturing processes in such a way that the latter must fulfill the goals of producing a large number of healthy as well as phenotypically & genotypically stable cells.
Moreover, stem cells, which are also referred to as Mesenchymal stem cells, are isolated by utilizing classic methods like ficoll gradient centrifugation as well as consequent cell fraction plating. Apart from this, Mesenchymal stem cells are adherent and can be easily separated from other kinds of cells in the initial phase of cell isolation through cell attachment in 2D tissue cell culture flasks.
Additionally, stem cells are utilized in allogenic or autologous approaches for manufacturing a cell lot that can manufacture multiple cell-based product units. In an autologous approach, stem cells are processed, harvested, and expanded and after that reintroduced into patients. Apparently, the use of the autologous method results in enhancing manufacturing controls in a regulated environment leading to the huge production of stem cells along with cost reduction & improved purity of cell-based products.
Humungous use of stem cells for treating myriad kinds of ailments will steer the growth of the stem cell manufacturing market over the upcoming years. Additionally, surging funding of stem-cell research activities, escalating awareness pertaining to the therapeutic potential of stem cell-based products, and favorable laws supporting stem-cell research in emerging economies will boost market trends. Large-scale awareness about treating cancer, degenerative ailments, and hematopoietic diseases through stem cell therapies will embellish market size over the assessment period. The rise in research activities in the pharma & biotech industries will provide impetus to the stem cell treatment market, thereby driving stem cell manufacturing market value over the years to come.
Furthermore, the delivery of cell-based treatments to market poses a unique risk in terms of both security & efficiency, and hence the massive acceptance of the risk-based model in the pharma sector has gained momentum in recent years. This is anticipated to create lucrative growth avenues for the stem cell manufacturing industry over the years to come. In addition to this, stem cells are garnering immense popularity due to their major role in effective disease management & specialized research events such as genomic testing & personalized drugs. This, in turn, will help the stem cell manufacturing business expand by leaps & bounds during the upcoming years.
North America Accounts Majorly Towards Overall Market Size By 2028
The growth of the stem cell manufacturing market in North America Over the forecast period is due to massive stem cell research activities in countries such as the U.S. In addition to this, easy access to private-public funding as well as government support for stem cell research & applications in Canada and the U.S. will proliferate regional market size. The rise in cell treatment and gene therapies in the sub-continent will boost the production of stem cells for biotech & clinical research as well as for human & animal trials, thereby paving way for the growth of stem cell manufacturing business in the sub-continent of North America. The presence of major participants in countries such as the U.S. and Canada will further enlarge the regional market scope in the upcoming years.
Stem cell manufacturing industry share is highly fragmented due to presence of giant players & new entrants. With need to establish competitive advantage, players in the market are trying to launch new stem cell manufacturing processes. Few of key players profiled in the study and leveraging market growth are Thermo Fisher Scientific, Inc., Lonza Group AG, Sartorius AG, Merck Milliopore, and Danahar Corporation.
The global Stem Cell Manufacturing Market is segmented as follows:
By End-User
By Application
By Product
By Region
List of Figures
1. Market research Type
2. Market research methodology
3. Global Stem Cell Manufacturing Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Stem Cell Manufacturing Marketattractiveness, By End-User
6. Global Stem Cell Manufacturing Marketattractiveness, By Application
7. Global Stem Cell Manufacturing Marketattractiveness, By Product
8. Global Stem Cell Manufacturing Marketshare by End-User ,2020 and 2028 (USD Billion)
9. Global Stem Cell Manufacturing Marketby Hospitals, 2018–2028(USD Billion)
10. Global Stem Cell Manufacturing Marketby Pharma & Biotech, 2018–2028(USD Billion)
11. Global Stem Cell Manufacturing Marketby Tissue Bank, 2018–2028(USD Billion)
12. Global Stem Cell Manufacturing Marketshare by Application ,2020 and 2028 (USD Billion)
13. Global Stem Cell Manufacturing Marketby Clinical Research, 2018–2028(USD Billion)
14. Global Stem Cell Manufacturing Marketby Cell & Tissue Banking, 2018–2028(USD Billion)
15. Global Stem Cell Manufacturing Marketshare by Product ,2020 and 2028 (USD Billion)
16. Global Stem Cell Manufacturing Marketby Consumables, 2018–2028(USD Billion)
17. Global Stem Cell Manufacturing Marketby Instrument, 2018–2028(USD Billion)
18. Global Stem Cell Manufacturing Marketby HSCs, 2018–2028(USD Billion)
19. Global Stem Cell Manufacturing Marketby MSCs, 2018–2028(USD Billion)
20. Global Stem Cell Manufacturing Marketby iPSCs, 2018–2028(USD Billion)
21. Global Stem Cell Manufacturing Marketby ESCs, 2018–2028(USD Billion)
22. Global Stem Cell Manufacturing Marketshare, by Region, 2020 and 2028
23. North America Stem Cell Manufacturing Market, 2018–2028(USD Billion)
24. Europe Stem Cell Manufacturing Market, 2018–2028(USD Billion)
25. Asia Pacific Stem Cell Manufacturing Market, 2018–2028(USD Billion)
26. Latin America Stem Cell Manufacturing Market, 2018–2028(USD Billion)
27. The Middle East and Africa Stem Cell Manufacturing Market, 2018–2028(USD Billion)
List of Tables
1. Global Stem Cell Manufacturing Market: snapshot
2. Drivers of the Stem Cell Manufacturing Market: impact analysis
3. North America Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
4. North America Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
5. North America Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
6. The U.S. Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
7. The U.S. Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
8. The U.S. Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
9. Rest of North America Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
10. Rest of North America Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
11. Rest of North America Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
12. Europe Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
13. Europe Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
14. Europe Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
15. UK Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
16. UK Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
17. UK Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
18. France Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
19. France Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
20. France Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
21. Germany Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
22. Germany Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
23. Germany Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
24. Rest of Europe Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
25. Rest of Europe Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
26. Rest of Europe Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
27. Asia Pacific Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
28. Asia Pacific Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
29. Asia Pacific Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
30. China Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
31. China Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
32. China Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
33. Japan Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
34. Japan Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
35. Japan Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
36. India Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
37. India Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
38. India Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
39. Rest of Asia Pacific Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
40. Rest of Asia Pacific Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
41. Rest of Asia Pacific Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
42. Latin America Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
43. Latin America Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
44. Latin America Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
45. Brazil Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
46. Brazil Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
47. Brazil Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
48. Rest of Latin America Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
49. Rest of Latin America Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
50. Rest of Latin America Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
51. The Middle East and Africa Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
52. The Middle East and Africa Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
53. The Middle East and Africa Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
54. Saudi Arabia Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
55. Saudi Arabia Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
56. Saudi Arabia Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
57. South Africa Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
58. South Africa Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
59. South Africa Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
60. Rest of the Middle East & Africa Stem Cell Manufacturing Market revenue, By End-User ,2018–2028(USD Billion)
61. Rest of the Middle East & Africa Stem Cell Manufacturing Market revenue, By Application ,2018–2028(USD Billion)
62. Rest of the Middle East & Africa Stem Cell Manufacturing Market revenue, By Product ,2018–2028(USD Billion)
Humungous use of stem cells for treating myriad kind of ailments will steer growth of stem cell manufacturing market over the upcoming years. Additionally, surging funding of stem-cell research activities, escalating awareness pertaining to therapeutic potential of stem cell-based products, and favorable laws supporting stem cell research in emerging economies will boost market trends. Large-scale awareness about treating cancer, degenerative ailments, and hematopoietic diseases through stem cell therapies will embellish market size over assessment period. Rise in research activities in pharma & biotech industries will provide impetus to stem cell treatment market, thereby driving stem cell manufacturing market value over the years to come.
Furthermore, delivery of cell-based treatments to market poses a unique risk in terms of both security & efficiency and hence massive acceptance of risk-based model in pharma sector has gained momentum in recent years. This is anticipated to create lucrative growth avenues for stem cell manufacturing industry over the years to come.
According to Zion market research report, the global Stem Cell Manufacturing market accrued earnings worth approximately 11.2(USD Billion) in 2020 and is predicted to gain revenue of about 21.1(USD Billion) by 2028, is set to record a CAGR of nearly 9.5% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to massive stem cell research activities in countries such as the U.S. In addition to this, easy access to private-public funding as well as government support for stem cell research & applications in Canada and the U.S. will proliferate regional market size. Rise in cell treatment and gene therapies in the sub-continent will boost production of stem cells for biotech & clinical research as well as for human & animal trials, thereby paving way for growth of stem cell manufacturing business in sub-continent of North America. Presence of major participants in countries such as the U.S. and Canada will further enlarge regional market scope in upcoming years.
The key market participants include Thermo Fisher Scientific, Inc., Lonza Group AG, Sartorius AG, Merck Milliopore, and Danahar Corporation.
Key applications of stem cell manufacturing include cancerous tissues, genetic disorders, degenerative ailments, and hematopoietic diseases. It also provides impetus to genomic testing activities and facilitates research in personalized medicine sector.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed